India, or certain other countries. Research A transdermal gel formulation of norgelstromin and ethinyl estradiol was under development by Antares Pharma for use as a method of birth control with the code name AP-1081 but development was discontinued. See also Ethinylestradiol/norelgestromin References Further reading External links Ethinylestradiol/norelgestromin transdermal - AdisInsight Tertiary alcohols Ethynyl compounds Androgens and anabolic steroids Estranes Hormonal contraception Human drug metabolites Progestogens Steroid oximes Ketoximes